Valence Discovery
Techstars '18Montréal, CA · 5 known investors
Valence Labs is Recursion's AI research engine that develops computational models to predict and explain cellular responses to treatments, with applications in drug discovery. The group builds virtual cells and machine learning tools to accelerate the identification of effective therapeutics.
AI & Machine LearningBiotechData & InfrastructureDeep TechHealthtechin /valence-discovery@valence_ai
Investors · 5
In the news
- Valence Discovery Announces $8.5 Million in Seed Funding — Amplify Capitalamplifycapital.ca · 2022
- Valence Discovery announces $10.9 million CAD for AI-aided drug discovery and formulationbetakit.com · 2021
- Valence Discovery Announces $8.5 Million in Seed Funding to Scale AI-Based Generative Chemistry Engine and Collaborations with Leading Discovery Organizations - BioSpacebiospace.com · 2021